<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Laser-Assisted In Situ Keratomileusis Lasers-Patient Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Laser-Assisted In Situ Keratomileusis Lasers-Patient Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability</h1>
    <p class="timestamp">Published: 2022-07-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Laser-Assisted In Situ Keratomileusis (LASIK) Lasers--Patient Labeling Recommendations." This draft guidance recommends content and formatting for patient labeling information for LASIK devices. FDA is issuing this guidance to help ensure that physicians can share and patients can understand information on the benefits and risks of these devices. The recommendations are being made base...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-16166</p>
    <p><strong>Publication Date:</strong> 2022-07-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/07/28/2022-16166/laser-assisted-in-situ-keratomileusis-lasers-patient-labeling-recommendations-draft-guidance-for">https://www.federalregister.gov/documents/2022/07/28/2022-16166/laser-assisted-in-situ-keratomileusis-lasers-patient-labeling-recommendations-draft-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-16166</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
